Veriskin is a medical device and technology company dedicated to facilitating and improving skin cancer screening accuracy. Non-specialist caregivers can be uncertain in their initial assessments, which leads to failure to detect cancer at an early, more treatable stage. That in turn can lead to increased costs from malpractice claims owing to false negative diagnoses as well as unnecessary specialist referrals and biopsies. Veriskin has developed a non-invasive, low-cost, hand-held device that helps non-expert users rapidly and objectively determine whether a suspect skin lesion is cancerous.
